Suprafascial Vancomycin Powder for Prevention of Surgical Site Infections After Instrumented Posterior Spinal Fusion
Condition: Surgical Site Infection · Sponsor: Insel Gruppe AG, University Hospital Bern
About this study
Surgical site infections (SSI) after spine surgery may occur in up to 12% of cases and can lead to increased morbidity, and healthcare costs In this randomized controlled trial the investigators aim to prospectively investigate the efficacy and safety of suprafascial intrawound vancomycin powder in reducing the rate of SSIs after instrumented spinal fusion surgery. Secondary aims of the study are the incidence of vancomycin-related complications, vancomycin-resistant bacterial infections in the treatment arm as well as the rate of revision surgeries due to SSIs.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (7)
| Kantonsspital St. Gallen | Sankt Gallen, Canton of St. Gallen, Switzerland | — |
| University Hostpital Bern, Department of Neurosurgery | Bern, Switzerland | — |
| University Hostpital Bern, Department of orthopaedy | Bern, Switzerland | — |
| Lindenhofspital Bern | Bern, Switzerland | — |
| Spitalzentrum Biel | Biel, Switzerland | — |
| Klinik St. Anna | Lucerne, Switzerland | — |
| University Hospital Zurich, Department of Neurosurgery | Zurich, Switzerland | — |
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04017468